A Study of V118 Formulation C (V118C) in Healthy Participants (V118C-001)

Completed · Phase 1

Conditions studied: Healthy

In brief

The goal of this study is to learn how safe V118 Formulation C is in Healthy Adults and how well people tolerate it.

Key facts

Study ID

NCT06611033

Run by

Merck Sharp & Dohme LLC

People needed

65

Starts

2024-09-25

Expected to finish

2026-01-09

Last updated by the study team

2026-01-20

Who can join

Age: 18 and older, up to 49. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• Has a history of invasive pneumococcal disease or known history of other culture-positive pneumococcal disease within 3 years prior to receiving study vaccination.
• Has a history of clinically significant endocrine, GI, cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases.

Where it is running

• Velocity Clinical Research, Hallandale Beach ( Site 0003) — Hallandale, Florida, United States
• Research Centers of America ( Hollywood ) ( Site 0002) — Hollywood, Florida, United States
• University of Texas Medical Branch ( Site 0001) — Galveston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.